BRIEF RESEARCH REPORT
Accepted on 10 Jun 2025
Efficacy and Safety of Ruxolitinib in Adult Patients with Refractory Rheumatic Disease-Associated Macrophage Activation Syndrome
doi 10.3389/fimmu.2025.1604648
- Frontiers in Immunology
- Inflammation
- Research Topics
- Community Series in Pathogenetic mechanism and therapeutic target for inflammation in autoimmune disease: Volume Ⅲ
Community Series in Pathogenetic mechanism and therapeutic target for inflammation in autoimmune disease: Volume Ⅲ
813
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.